營收首破10億大關 天韻國際控股(06836.HK)全年純利升14.6%至1.69億元
格隆匯3月31日丨天韻國際控股(06836.HK)公佈,截至2019年12月31日止年度,集團實現收益10.63億元人民幣(單位下同),同比增長13.0%,首次超越10億元大關;毛利2.96億元,同比增長12.4%;公司權益持有人應占溢利1.69億元,同比增長14.6%;每股基本盈利17.20分,擬派末期股息每股3港仙。
自家品牌業務繼續保持高速增長勢頭,該分部收入更上升31.0%至6.32億元(未經審核),佔集團總收入59.4%,此意味着集團以自家品牌為主導的食品消費品企業營運策略取得成功。另外,集團的OEM業務繼續穩定發展,與國際知名食品品牌商合作無間,客户羣體不斷拓展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.